Cutaneous Infection with Mycobacterium fortuitum after Localized Microinjections (Mesotherapy) Treated Successfully with a Triple Drug Regimen

Nagore, Eduardo; Ramos, Pilar; Botella-Estrada, Rafael; Ramos-Ñíguez, José A.; Sanmartín, Onofre; Castejón, Pilar
August 2001
Acta Dermato-Venereologica;Aug/Sep2001, Vol. 81 Issue 4, p291
Academic Journal
Mesotherapy is a treatment method devised for controlling pain syndromes or diseases by subcutaneous microinjections given at or around the involved areas at short intervals of time. Different adverse effects have been described due to this modality of treatment. This report describes 3 patients with cutaneous infection caused by Mycobacterium fortuitum after mesotherapy. Three women, aged 24, 27 and 44 years, presented with similar clinical features, consisting of painful nodules located at the points where mesotherapy had been applied. A smear from a skin biopsy revealed the presence of acid-fast bacilli in all 3 cases. The specimen was cultured and eventually identified as M. fortuitum. A multidrug long-term regimen (combinations of 3 drugs from the following: ciprofloxacin, cotrimoxazole, clarithromycin and amoxicillin-clavulanic acid) was needed to achieve resolution of the lesions. After 15, 25 and 26 months of follow-up, no patient relapsed. Mycobacterium fortuitum is a rapidly growing mycobacterium that can lead to cutaneous infection after minor surgical procedures when aseptic measures are not adequate. Multiple drugs for several months are usually needed to treat this disease successfully.


Related Articles

  • Improving safety and health practice at a scientific... Teleki, Emil; Foldes, Andrew // Professional Safety;May96, Vol. 41 Issue 5, p38 

    Reports on research carried out at the Prospect Laboratory of Australia's Commonwealth Scientific and Industrial Research Organization (CSIRO), on transgenisis with the use of microinjections. What does the microinjection technique consist of; Look at three case studies; Modifications...

  • Methylphenidate Disrupts Social Play Behavior in Adolescent Rats. Vanderschuren, Louk J. M. J.; Trezza, Viviana; Griffioen-Roose, Sanne; Schiepers, Olga J. G.; Van Leeuwen, Natascha; De Vries, Taco J.; Schoffelmeer, Anton N. M. // Neuropsychopharmacology;Nov2008, Vol. 33 Issue 12, p3021 

    A correction to the article "Methylphenidate Disrupts Social Play Behavior in Adolescent Rats," that was published November 1, 2008 issue is presented.

  • Mycobacterium tuberculosis-Associated Necrotizing Pneumonia With Adjunctive Corticosteroid Therapy. Nguyen, Ho Lam; Duong Thanh, Huyen; Le, Thuong Vu; Tran Van, Ngoc // Case Reports in Infectious Diseases;7/1/2019, p1 

    Necrotizing pneumonia induced by Mycobacterium tuberculosis is a rare but severe condition. It is difficult to distinguish between M. tuberculosis-associated and bacterial necrotizing pneumonia. The optimal treatment for this condition is controversial. Here, we report a case of M....

  • Clarithromycin provides clearance of MAC bacteremia.  // AIDS Patient Care & STDs;Feb1997, Vol. 11 Issue 1, p38 

    Reports on Clarithromycin's significant difference compared with azithromycin in treating mycobacterium avium complex (MAC) infections in AIDS patients who are positive for MAC bacteremia. Only drug approved for both treatment and prophylaxis of MAC infection.

  • Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK signal transduction pathway. Chie, L.; Amar, S.; Kung, H.-F.; Lin, M. C. M.; Chen, H.; Chung, D. L.; Adler, V.; Ronai, Z.; Friedman, F. K.; Robinson, R. C.; Kovac, C.; Brandt-Rauf, P. W.; Yamaizumi, Z.; Michl, J.; Pincus, M. R.; Lin, M C // Cancer Chemotherapy & Pharmacology;Jun2000, Vol. 45 Issue 6, p441 

    Purpose: We have previously found that microinjection of activated MEK (mitogen activated kinase kinase) and ERK (mitogen-activated protein; MAP kinase) fails to induce oocyte maturation, but that maturation, induced by oncogenic ras-p21 and insulin-activated cell ras-p21, is...

  • Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013. Brode, Sarah K.; Hannah Chung; Campitelli, Michael A.; Kwong, Jeffrey C.; Marchand-Austin, Alex; Winthrop, Kevin L.; Jamieson, Frances B.; Marras, Theodore K.; Chung, Hannah // Emerging Infectious Diseases;Jul2019, Vol. 25 Issue 7, p1271 

    Surveys suggest that clinicians diverge from guidelines when treating Mycobacterium avium complex (MAC) pulmonary disease (PD). To determine prescribing patterns, we conducted a cohort study of adults >66 years of age in Ontario, Canada, with MAC or Mycobacterium xenopi PD during 2001-2013....

  • Two Faces of MAC-Induced Lung Disease. Tetenta, Sodienye; Abunasser, Jafar; Bandyopadhyay, Tapas // Connecticut Medicine;Apr2008, Vol. 72 Issue 4, p203 

    Lung disease due to mycobacterium avium complex (MAC) is being increasingly recognized. The clinical and radiological manifestations are varied and treatment is complex. We present two cases of MAC-induced lung disease to illustrate this disease.

  • A retrospective study of the addition of ciprofloxacin to clarithromycin and ethambutol in the treatment of disseminated Mycobacterium avium complex infection. Keiser, Philip; Nassar, Naiel; Skiest, Daniel; Rademacher, Steven; Smith, James W; Keiser, P; Nassar, N; Skiest, D; Rademacher, S; Smith, J W // International Journal of STD & AIDS;Dec1999, Vol. 10 Issue 12, p791 

    Disseminated Mycobacterium avium complex (DMAC) infection is associated with increased morbidity and mortality in HIV-infected individuals. The combination antibiotic regimens containing clarithromycin can decrease symptoms and improve survival in patients with DMAC, however, optimal therapy...

  • Effect of Potent Antiretroviral Therapy on Immune Responses to Mycobacterium avium in Human Immunodeficiency Virus-Infected Subjects. Havlir, Diane V.; Schrier, Rachel D.; Torriani, Francesca J.; Chervenak, Keith; Hwang, Jimmy Y.; Boom, W. Henry // Journal of Infectious Diseases;12/1/2000, Vol. 182 Issue 6 

    To characterize the influence of highly active antiretroviral therapy (HAART) on cell-mediated immunity (CMI) to Mycobacterium avium complex (MAC), we measured immune responses to M. avium in human immunodeficiency virus (HIV)-infected individuals before and during HAART, in subjects with a...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics